Evidence-based
Every staging boundary rests on published evidence.
VERISYN.CO
VERISYN.CO
Quantitative imaging biomarkers
Traceable. Honest about its limits. Built for scrutiny.
VERISYN.CO builds quantitative imaging tools that hold up to scrutiny. Every value a report shows traces to a named, published source; where the evidence is not settled, the tool says so rather than fill the gap. That discipline is the standard behind every product we build.
Runveri.LiverThe page is public so practising radiologists can test veri.Liver's output under real-world conditions — open a report and flag anything it should handle better.
01 The first product
A quantitative liver-MRI report. Iron, fat, fibrosis and stiffness — measured, staged, and shown with the evidence behind each boundary.
Reliable quantitative reading, within reach of a physician who is not a subspecialist.
02 The standard
Every staging boundary rests on published evidence.
Open any result to its source, cited on the report.
Where the evidence is unsettled, the report says so.
Iron, fat, fibrosis and stiffness read together, not apart.
03 How it's built
The liver-MRI literature is large, scattered, and shifting. Weighing all of it to a defensible stage, case by case, is not realistic for a non-subspecialist. veri.Liver is that synthesis — assembled with AI into one logical framework: the subspecialist reading, in one place.
No model in the loop when a report is made. Every boundary resolves to a published cut-off you can open and check.
04 Available
Single-patient quantitative liver MRI — iron, fat, fibrosis and stiffness, staged and printed as two A4 pages. Vendor-neutral, works offline with nothing to install, and no study ever leaves your machine.